Balance Sheet NovoCure Limited

Equities

NVCR

JE00BYSS4X48

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 01:41:38 2025-01-22 pm EST			5-day change	1st Jan Change
26.41 ^USD	-2.04%		-0.30%	-11.85%

Dec. 02	HC Wainwright Adjusts NovoCure Price Target to $38 From $30, Maintains Buy Rating	MT
Dec. 02	NovoCure's Shares Rise as Pancreatic Cancer Trial Meets Primary Endpoint	MT

342300795c67017b82d30.dCmj5Dub3r3H9xRSnDdeuNvhfpR5BchW4dOlKr_pqvk.A0_7jnDPqImRniFjyFEW1ZC1Df8fbJEGhJXQa_u22pgZGsbdTqOU-_W1QQ

Published financial data: NOVOCURE LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	351M	494M	535M	538M	509M
Total Revenues	351M	494M	535M	538M	509M
Cost of Goods Sold, Total	88.28M	106M	114M	114M	128M
Gross Profit	263M	388M	421M	424M	382M
Selling General & Admin Expenses, Total	185M	225M	263M	306M	387M
R&D Expenses	79M	132M	201M	206M	221M
Other Operating Expenses, Total	264M	357M	464M	512M	608M
Operating Income	-587K	30.81M	-43.69M	-88.91M	-226M
Interest Expense, Total	-13.87M	-17.66M	-3.44M	-3.33M	-3.32M
Interest And Investment Income	4.4M	1.79M	791K	10.96M	19.64M
Net Interest Expenses	-9.47M	-15.87M	-2.65M	7.63M	16.32M
Currency Exchange Gains (Loss)	-431K	2.65M	-4.03M	-3.52M	-797K
Other Non Operating Income (Expenses)	-338K	-389K	-1.37M	-1.26M	-790K
EBT, Excl. Unusual Items	-10.83M	17.2M	-51.74M	-86.06M	-211M
Restructuring Charges	-	-	-	-	-6.23M
Gain (Loss) On Sale Of Investments	2.33M	1.32M	306K	4.83M	26.4M
Asset Writedown	-327K	-409K	-639K	-611K	-483K
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-8.82M	18.1M	-52.08M	-81.85M	-192M
Income Tax Expense	-1.59M	-1.71M	6.28M	10.69M	15.3M
Earnings From Continuing Operations	-7.23M	19.81M	-58.35M	-92.53M	-207M
Net Income to Company	-7.23M	19.81M	-58.35M	-92.53M	-207M
Net Income - (IS)	-7.23M	19.81M	-58.35M	-92.53M	-207M
Net Income to Common Incl Extra Items	-7.23M	19.81M	-58.35M	-92.53M	-207M
Net Income to Common Excl. Extra Items	-7.23M	19.81M	-58.35M	-92.53M	-207M
Per Share Items
Net EPS - Basic	-0.07	0.2	-0.56	-0.88	-1.95
Basic EPS - Continuing Operations	-0.07	0.2	-0.56	-0.88	-1.95
Basic Weighted Average Shares Outstanding	97.24M	101M	103M	105M	106M
Net EPS - Diluted	-0.07	0.18	-0.56	-0.88	-1.95
Diluted EPS - Continuing Operations	-0.07	0.18	-0.56	-0.88	-1.95
Diluted Weighted Average Shares Outstanding	97.24M	109M	103M	105M	106M
Normalized Basic EPS	-0.07	0.11	-0.31	-0.51	-1.24
Normalized Diluted EPS	-0.07	0.1	-0.31	-0.51	-1.24
Supplemental Items
EBITDA	6.19M	38.56M	-34.53M	-79.34M	-216M
EBITA	-587K	30.81M	-43.69M	-88.91M	-226M
EBIT	-587K	30.81M	-43.69M	-88.91M	-226M
EBITDAR	10.8M	44.51M	-27.18M	-72.24M	-208M
Effective Tax Rate - (Ratio)	18.06	-9.42	-12.05	-13.06	-7.98
Current Foreign Taxes	-1.74M	-1.71M	6.28M	10.69M	15.3M
Total Current Taxes	-1.74M	-1.71M	6.28M	10.69M	15.3M
Deferred Foreign Taxes	144K	-	-	-	-
Total Deferred Taxes	144K	-	-	-	-
Normalized Net Income	-6.77M	10.75M	-32.34M	-53.79M	-132M
Interest on Long-Term Debt	14.21M	18.05M	4.81M	4.59M	3.38M
Non-Cash Pension Expense	52K	105K	-421K	-621K	-320K
Supplemental Operating Expense Items
Selling and Marketing Expenses	96.68M	118M	137M	174M	224M
General and Administrative Expenses	87.95M	107M	126M	133M	163M
Research And Development Expense From Footnotes	79M	132M	201M	206M	223M
Net Rental Expense, Total	4.61M	5.95M	7.35M	7.11M	8.2M
Imputed Operating Lease Interest Expense	3.22M	2.74M	394K	325K	366K
Imputed Operating Lease Depreciation	1.39M	3.21M	6.95M	6.78M	7.83M
Stock-Based Comp., COGS (Total)	2.23M	2.22M	3.47M	4.69M	6.59M
Stock-Based Comp., R&D Exp. (Total)	7.57M	18.12M	27.6M	30.79M	31.83M
Stock-Based Comp., S&M Exp. (Total)	11.9M	17.67M	22.67M	28.83M	35.97M
Stock-Based Comp., G&A Exp. (Total)	30.72M	37.7M	41.16M	42.65M	41.23M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	52.42M	75.72M	94.9M	107M	116M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	177M	235M	209M	115M	241M
Short Term Investments	149M	608M	729M	854M	670M
Total Cash And Short Term Investments	326M	843M	938M	969M	911M
Accounts Receivable, Total	58.86M	96.7M	93.57M	86.26M	61.22M
Other Receivables	21.38M	13.36M	8.42M	12.39M	5.26M
Total Receivables	80.24M	110M	102M	98.65M	66.48M
Inventory	23.7M	27.42M	24.43M	29.38M	38.15M
Prepaid Expenses	2.72M	4.12M	4.76M	6.42M	6.85M
Restricted Cash	2.1M	11.5M	807K	508K	1.74M
Other Current Assets, Total	5.1M	3.77M	3.84M	7.15M	10.56M
Total Current Assets	440M	999M	1.07B	1.11B	1.03B
Gross Property Plant And Equipment	62.64M	76.71M	96.84M	117M	153M
Accumulated Depreciation	-28.04M	-35.07M	-42.96M	-47.64M	-54.81M
Net Property Plant And Equipment	34.6M	41.63M	53.88M	68.96M	97.7M
Other Long-Term Assets, Total	4.9M	10.91M	12.09M	11.16M	14.02M
Total Assets	479M	1.05B	1.14B	1.19B	1.15B
Liabilities
Accounts Payable, Total	36.92M	53.65M	72.6M	85.2M	94.39M
Accrued Expenses, Total	20.9M	35.66M	45.39M	49.44M	60.18M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	4.64M	6.48M	6.68M	5.8M	8.22M
Current Income Taxes Payable	12.01M	-	-	-	-
Unearned Revenue Current, Total	11.77M	17.76M	17.76M	18.03M	16.22M
Other Current Liabilities	63K	61K	169K	310K	98K
Total Current Liabilities	86.31M	114M	143M	159M	179M
Long-Term Debt	149M	430M	562M	566M	569M
Long-Term Leases	14.14M	14.29M	13M	18.76M	27.42M
Unearned Revenue Non Current	7.81M	12.14M	6.48M	2.88M	-
Pension & Other Post Retirement Benefits	3.75M	5.17M	4.54M	4.4M	8.26M
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	156K	297K	154K	76K	18K
Total Liabilities	262M	575M	729M	750M	784M
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	-	-	-	-	-
Additional Paid In Capital	871M	1.11B	1.1B	1.22B	1.35B
Retained Earnings	-651M	-631M	-686M	-778M	-986M
Comprehensive Income and Other	-2.77M	-3.83M	-3.17M	-2.43M	-5.47M
Total Common Equity	218M	477M	410M	441M	362M
Total Equity	218M	477M	410M	441M	362M
Total Liabilities And Equity	479M	1.05B	1.14B	1.19B	1.15B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	99.64M	102M	104M	105M	107M
ECS Total Common Shares Outstanding	99.53M	102M	104M	105M	107M
Book Value / Share	2.19	4.66	3.95	4.2	3.39
Tangible Book Value	218M	477M	410M	441M	362M
Tangible Book Value Per Share	2.19	4.66	3.95	4.2	3.39
Total Debt	168M	451M	582M	590M	604M
Net Debt	-158M	-392M	-356M	-379M	-306M
Debt Equivalent of Unfunded Proj. Benefit Obligation	3.33M	4.67M	4.01M	3.9M	7.81M
Debt Equivalent Oper. Leases	36.86M	47.6M	58.79M	56.86M	65.57M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	3.91M	5.18M	1.48M	4.31M	10.26M
Inventories - Work In Process, Total	6.48M	4.9M	8.27M	9.32M	9.8M
Inventories - Finished Goods, Total	13.31M	17.35M	14.67M	15.74M	18.09M
Land - (BS)	-	-	11.16M	15.99M	24.7M
Machinery, Total	19.17M	23.32M	26.56M	30.94M	43.05M
Full Time Employees	782	1.02K	1.17K	1.32K	1.45K
Assets on Operating Lease - Gross	21.08M	27.88M	33.79M	36.73M	38.24M
Assets on Operating Lease - Accumulated Depreciation	-13.39M	-16.65M	-20.87M	-24.04M	-26.85M
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-7.23M	19.81M	-58.35M	-92.53M	-207M
Depreciation & Amortization - CF	6.78M	7.75M	9.17M	9.57M	9.7M
Depreciation & Amortization, Total	6.78M	7.75M	9.17M	9.57M	9.7M
Amortization of Deferred Charges, Total - (CF)	1.84M	5.91M	4.42M	4.35M	4.59M
(Gain) Loss on Sale of Investments - (CF)	-2.33M	-1.25M	-238K	-4.83M	-26.4M
Asset Writedown & Restructuring Costs	398K	429K	649K	955K	493K
Stock-Based Compensation (CF)	52.42M	75.72M	94.9M	107M	116M
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	-916K	-699K	3.14M	-5.47M	66K
Change In Accounts Receivable	-36.5M	-30.35M	5.27M	2.55M	29.41M
Change In Inventories	-1.16M	-2.94M	2.48M	-4.34M	-8.92M
Change In Accounts Payable	16.88M	25.47M	27.78M	14.26M	14.87M
Change in Other Net Operating Assets	-3.56M	-702K	-6.46M	-666K	-5.71M
Cash from Operations	26.62M	99.15M	82.76M	30.79M	-73.34M
Capital Expenditure	-10.48M	-14.97M	-24.17M	-21.36M	-27.09M
Investment in Marketable and Equity Securities, Total	-41.18M	-458M	-121M	-119M	211M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-51.67M	-473M	-145M	-140M	184M
Long-Term Debt Issued, Total	-	558M	-	-	-
Total Debt Issued	-	558M	-	-	-
Long-Term Debt Repaid, Total	-31K	-150M	-26K	-28K	-10K
Total Debt Repaid	-31K	-150M	-26K	-28K	-10K
Issuance of Common Stock	61.71M	31.8M	25.73M	15.52M	15.8M
Repurchase of Common Stock	-	-	-	-	-
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	61.68M	440M	25.7M	15.49M	15.79M
Foreign Exchange Rate Adjustments	26K	247K	-188K	-97K	131K
Net Change in Cash	36.66M	66.76M	-36.56M	-93.78M	127M
Supplemental Items
Cash Interest Paid	13.7M	8.69M	101K	41K	6K
Cash Income Tax Paid (Refund)	11.24M	-3.26M	3.11M	5.48M	13.66M
Levered Free Cash Flow	20.26M	60.45M	98.21M	45.95M	-10.2M
Unlevered Free Cash Flow	28.77M	66.97M	97.02M	44.74M	-11.44M
Change In Net Working Capital	21.25M	22.19M	-43.34M	-4.09M	-30.42M
Net Debt Issued / Repaid	-31K	408M	-26K	-28K	-10K

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-0.09	2.51	-2.49	-4.77	-12.09
Return on Total Capital	-0.11	2.94	-2.85	-5.51	-14.19
Return On Equity %	-4.38	5.71	-13.16	-21.73	-51.52
Return on Common Equity	-4.38	5.71	-13.16	-21.73	-51.52
Margin Analysis
Gross Profit Margin %	74.87	78.54	78.65	78.76	74.96
SG&A Margin	52.55	45.6	49.19	56.97	75.97
EBITDA Margin %	1.76	7.8	-6.45	-14.75	-42.5
EBITA Margin %	-0.17	6.23	-8.17	-16.53	-44.4
EBIT Margin %	-0.17	6.23	-8.17	-16.53	-44.4
Income From Continuing Operations Margin %	-2.06	4.01	-10.91	-17.2	-40.65
Net Income Margin %	-2.06	4.01	-10.91	-17.2	-40.65
Net Avail. For Common Margin %	-2.06	4.01	-10.91	-17.2	-40.65
Normalized Net Income Margin	-1.93	2.17	-6.04	-10	-25.94
Levered Free Cash Flow Margin	5.77	12.23	18.36	8.54	-2
Unlevered Free Cash Flow Margin	8.19	13.55	18.13	8.32	-2.25
Asset Turnover
Asset Turnover	0.86	0.65	0.49	0.46	0.44
Fixed Assets Turnover	14.06	12.97	11.2	8.76	6.11
Receivables Turnover (Average Receivables)	7.37	6.36	5.62	5.98	6.91
Inventory Turnover (Average Inventory)	3.82	4.15	4.41	4.25	3.78
Short Term Liquidity
Current Ratio	5.1	8.8	7.53	7	5.78
Quick Ratio	4.71	8.38	7.29	6.73	5.46
Operating Cash Flow to Current Liabilities	0.31	0.87	0.58	0.19	-0.41
Days Sales Outstanding (Average Receivables)	49.55	57.58	64.9	61.02	52.84
Days Outstanding Inventory (Average Inventory)	95.63	88.18	82.83	85.94	96.63
Average Days Payable Outstanding	129.86	150.94	207.11	241.58	240.44
Cash Conversion Cycle (Average Days)	15.31	-5.17	-59.38	-94.63	-90.97
Long Term Solvency
Total Debt/Equity	77.26	94.58	141.76	133.77	166.75
Total Debt / Total Capital	43.59	48.61	58.64	57.22	62.51
LT Debt/Equity	75.13	93.22	140.13	132.45	164.48
Long-Term Debt / Total Capital	42.39	47.91	57.96	56.66	61.66
Total Liabilities / Total Assets	54.57	54.7	63.98	62.98	68.37
EBIT / Interest Expense	-0.04	1.74	-12.7	-26.67	-68.14
EBITDA / Interest Expense	0.78	2.52	-7.9	-21.67	-62.75
(EBITDA - Capex) / Interest Expense	0.02	1.67	-14.93	-28.07	-70.91
Total Debt / EBITDA	15.58	10.13	-21.41	-8.17	-2.9
Net Debt / EBITDA	-14.62	-8.8	13.09	5.25	1.47
Total Debt / (EBITDA - Capex)	537.59	15.26	-11.33	-6.31	-2.57
Net Debt / (EBITDA - Capex)	-504.23	-13.26	6.93	4.05	1.3
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	41.62	40.72	8.23	0.52	-5.3
Gross Profit, 1 Yr. Growth %	56.23	47.61	8.38	0.66	-9.86
EBITDA, 1 Yr. Growth %	-123.99	522.87	-189.54	129.8	172.81
EBITA, 1 Yr. Growth %	-98.24	-5.35K	-241.82	103.49	154.36
EBIT, 1 Yr. Growth %	-98.24	-5.35K	-241.82	103.49	154.36
Earnings From Cont. Operations, 1 Yr. Growth %	-88.62	-373.97	-394.58	58.58	123.75
Net Income, 1 Yr. Growth %	-88.62	-373.97	-394.58	58.58	123.75
Normalized Net Income, 1 Yr. Growth %	-77.24	-258.8	-400.91	66.33	145.66
Diluted EPS Before Extra, 1 Yr. Growth % <